Committed to developing treatments
for orphan diseases
Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.
 |
 |
 |
Cystic Fibrosis |
Science |
LAU-7b |
Events
Laurent Pharmaceuticals to participate at the BioPharm America, September 26-27th 2017, Boston, MA, USA
Laurent Pharmaceuticals to participate at the BIO International Convention, June 19-22th 2017, San Diego, CA, USA
News
Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis
Laurent Pharmaceuticals Receives US$ 3M Development Award From Cystic Fibrosis Foundation Therapeutics
First Canadian Company To Obtain CFFT Therapeutics Development Award